On October 30th, the Massachusetts Joint Committee on Health Care Financing reported a bill favorably to the Senate. The bill, S 2492 “An Act relative to pharmaceutical access, costs and transparency,” combined several previously pending bills that NACDS had been monitoring and advocating. The new bill includes PBM (Pharmacy Benefit Manager) regulation, PBM transparency, and drug cost containment. The bill is now pending action before the Senate Ways and Means Committee. The Massachusetts legislative session will continue until July 31, 2024.
The Massachusetts Board of Pharmacy announced three new updated policies on November 2nd:
- Prescribing and Dispensing of Contraceptives;
Update on Compliance Packaging and Reusable Dose Planners; and - CE requirements for pain management training for CDTM pharmacists
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.